A Phase 2 Study of Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Junction (GEJ) Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Study of LY3023414 and Necitumumab in Squamous Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Galcanezumab in Participants With Chronic Cluster Headache
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein
- Status
- COMPLETED
- Phase
- PHASE3
Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP)
- Status
- COMPLETED
- Phase
- PHASE4
The Forteo Alendronate Comparator Trial
- Status
- COMPLETED
- Phase
- PHASE4
Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)
- Status
- COMPLETED
- Phase
- PHASE3
Lipidomics Screening of Celecoxib in ex Vivo Human Whole Blood Assay - Part B
- Status
- COMPLETED
- Phase
- NA
A Study of Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Drug-Drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents
- Status
- COMPLETED
- Phase
- PHASE3